awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50311224-192B2F8E-B51E-4210-9623-664CE42D1658
Q50311224-192B2F8E-B51E-4210-9623-664CE42D1658
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50311224-192B2F8E-B51E-4210-9623-664CE42D1658
Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.
P2860
Q50311224-192B2F8E-B51E-4210-9623-664CE42D1658
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50311224-192B2F8E-B51E-4210-9623-664CE42D1658
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a9b47aaf29cf4551ff335d680a35ba773976f5e6
P2860
S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial